Pirtobrutinib: a promising therapy for overcoming the resistance of ibrutinib in mantle cell lymphoma

被引：0
|
作者：
Fatima, Sania Kaneez [1 ]
Khan, Sara [1 ]
Mughal, Zaib Un Nisa [1 ]
Rangwala, Hussain Sohail [1 ]
Rangwala, Burhanuddin Sohail [1 ]
Siddiq, Mohammad Arham [1 ]
Ali, Mirha [1 ]
Farah, Asma Ahmed [2 ,3 ]
机构：
[1] Jinnah Sindh Med Univ, Dept Med, Karachi, Pakistan
[2] East Africa Univ, Dept Med, Bosaso, Somalia
[3] East Africa Univ, 66R3 CC4, Boosaaso, Somalia
来源：
ANNALS OF MEDICINE AND SURGERY | 2024年 / 86卷 / 06期
关键词：
INHIBITOR; BRUIN;
D O I：
10.1097/MS9.0000000000002045
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3189 / 3191
页数：3
相关论文
共 50 条
  • [41] Ibrutinib-associated Serositis in Mantle Cell Lymphoma
    Styskel, Brett A.
    Lopez-Mattei, Juan
    Jimenez, Carlos A.
    Stewart, John
    Hagemeister, Fredrick B.
    Faiz, Saadia A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199 (12) : E43 - E44
  • [42] Diagnostically challenging immunophenotypic shift in mantle cell lymphoma following ibrutinib and venetoclax therapy
    Leitinger, E. J.
    Wright, R. M.
    Nelson, N.
    Anderson, M. A.
    Juneja, S.
    PATHOLOGY, 2021, 53 (07) : 926 - 929
  • [43] Ibrutinib and venetoclax combination therapy for mantle cell lymphoma: are two better than one?
    Li, Jian
    Tam, Constatine S.
    EXPERT REVIEW OF HEMATOLOGY, 2024, 17 (12) : 885 - 889
  • [44] Diffuse Alveolar Hemorrhage Secondary to Ibrutinib Therapy in a Patient With Refractory Mantle Cell Lymphoma
    Locke, Clifford B., Jr.
    Lansigan, Frederick
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (06)
  • [45] CDK9 As a New Therapeutic Vulnerability for Ibrutinib Resistance Mantle Cell Lymphoma (MCL)
    Wang, Michelle
    Zhao, Xiaohong
    Jiang, Huijuan
    Yan, Joy Catherine
    Sotomayor, Eduardo
    Shain, Kenneth H.
    Shah, Bijal
    Tao, Jianguo
    BLOOD, 2020, 136
  • [46] Targeting the Paracaspase MALT1: A Potential Therapy to Overcome Ibrutinib Resistance in Relapsed/Refractory Mantle Cell Lymphoma Patients
    Jiang, Changying
    Huang, Shengjian
    Liu, Yang
    Li, Carrie
    Guo, Hui
    Wang, Jeffrey
    Lopez, Elyse
    Zhang, Hui
    Lorence, Elizabeth A.
    Merolle, Maria
    Balaji, Swathi
    Ahmed, Makhdum
    Nomie, Krystle
    Lin, Xin
    Zhang, Liang
    Wang, Michael
    BLOOD, 2017, 130
  • [47] The efficacy of ibrutinib-based combination therapy for mantle cell lymphoma: A systematic review.
    Thirunagari, Prem
    Siyahian, Aida
    Iftikhar, Ahmad
    Wahab, Ahsan
    Ashraf, Afia
    Majeed, Ammara
    Parr, Nadia C. Nunes Cavalcante
    Russ, Atlantis Dawn
    Kumar, Abhijeet
    Anwer, Faiz
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [48] IBRUTINIB FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA AND MANTLE CELL LYMPHOMA
    McDermott, J.
    Jimeno, A.
    DRUGS OF TODAY, 2014, 50 (04) : 291 - 300
  • [49] Ibrutinib: a strong candidate for the future of mantle cell lymphoma treatment
    Zhang, Liang
    Newberry, Kate J.
    Wang, Michael
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2013, 9 (06) : 495 - 497
  • [50] IBRUTINIB PLUS PALBOCICLIB HAS EFFICACY IN MANTLE CELL LYMPHOMA
    不详
    CANCER DISCOVERY, 2019, 9 (03) : 318 - 318
12345